A detailed history of Orion Portfolio Solutions, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 3,286 shares of UTHR stock, worth $1.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,286
Previous 2,053 60.06%
Holding current value
$1.23 Million
Previous $653,000 80.25%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$311.04 - $363.55 $383,512 - $448,257
1,233 Added 60.06%
3,286 $1.18 Million
Q2 2024

Aug 13, 2024

BUY
$228.26 - $319.04 $33,554 - $46,898
147 Added 7.71%
2,053 $653,000
Q1 2024

May 09, 2024

SELL
$210.76 - $249.51 $24,869 - $29,442
-118 Reduced 5.83%
1,906 $437,000
Q4 2023

Feb 09, 2024

SELL
$214.88 - $256.94 $35,884 - $42,908
-167 Reduced 7.62%
2,024 $445,000
Q3 2023

Nov 01, 2023

BUY
$211.82 - $248.24 $108,240 - $126,850
511 Added 30.42%
2,191 $494,000
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $30,368 - $34,482
148 Added 9.66%
1,680 $370,000
Q1 2023

Aug 30, 2023

SELL
$212.99 - $276.17 $31,522 - $40,873
-148 Reduced 8.81%
1,532 $343,000
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $326,300 - $423,092
1,532 New
1,532 $343,000
Q3 2020

Nov 13, 2020

SELL
$99.9 - $121.13 $11,788 - $14,293
-118 Closed
0 $0
Q2 2020

Aug 19, 2020

SELL
$92.74 - $125.82 $741 - $1,006
-8 Reduced 6.35%
118 $14,000
Q1 2020

May 15, 2020

BUY
$79.39 - $115.35 $6,351 - $9,228
80 Added 173.91%
126 $12,000
Q4 2019

Feb 14, 2020

BUY
$78.31 - $95.34 $3,602 - $4,385
46 New
46 $4,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.